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a b s t r a c t
This article explores the spatio-temporal logics at work in global health. Inﬂuenced by ideas of time–
space compression, the global health literature argues that the world is characterised by a convergence of
disease patterns and biomedical knowledge. While not denying the inﬂuence of these temporalities and
spatialities of globalisation within the global health and chronic disease ﬁeld, the article argues that they
sit alongside other, often-conﬂicting notions of time and space. To do so, it explores the spatio-temporal
logics that underpin a highly inﬂuential epidemiological model of the smoking epidemic. Unlike the
temporalities and spatialities of sameness described in much of the global health literature, the article
shows that this model is articulated around temporalities and spatialities of difference. This is not the
difference celebrated by postmoderns, but the difference of modernisation theorists built around nations,
sequential stages and progress. Indeed, the model, in stark contrast to the ‘one world, one time, one
health’ globalisation mantra, divides the world into nation–states and orders them along epidemiolo-
gical, geographical and development lines.
& 2015 The Author. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Inﬂuenced by the theories on globalisation that became so
pervasive after the end of the Cold War, many of those who have
written on global health assume that the last decades of the
twentieth century have been marked by an accelerated com-
pression of time and space (e.g. Beaglehole and McMichael, 1999;
Walt, 2000). For them, the world has become a global village
characterised by political, economic, and social integration as
well as temporal simultaneity. This, they contend, is the con-
sequence of trade liberalisation policies and technological in-
novations like air travel and the Internet, which have brought
about growing ﬂows of people, knowledge, capital and goods
around the world. Applying these ideas to public health and
biomedicine, these commentators explain that the world we now
live in is characterised by a convergence of disease patterns,
biomedical knowledge and public health strategies. Often these
arguments have been made in relation to infectious diseases, as
with the idea that air travel has allowed for the rapid spread of
microbes around the global (e.g. Garrett, 1995; Youde, 2012).
More importantly for us, similar ideas have also been articulated
about non-communicable diseases (NCDs) and their risk factors
and, speciﬁcally, the smoking epidemic and the chronic diseases
it contributes to (e.g. Yach and Bettcher, 1999; Lee, 2003). So, for
example, many commentators have argued that smoking and
lung cancer are a global epidemic caused by trade liberalisation
and multinational tobacco companies. Likewise, others have ar-
gued that ‘global advocacy’ in the ﬁeld of tobacco control was
made possible by the Internet, which allowed activists from
around the world to ‘interact simultaneously’ (e.g. Yach and
Bettcher, 2000; Lee and Collin, 2005).
There is little doubt that these temporalities and spaces of globa-
lisation shape many theories, practices and materialities in today's
global health and chronic disease complex (McGoey et al., 2011). But,
as an emerging body of research suggests, there are other, often-
conﬂicting spatio-temporal logics at work within this complex (e.g.
Tousignant, 2013; Beisel, 2014; cf. also Lakoff and Collier, 2008; Fassin,
2012; Anderson, 2014). This article contributes to this research by ar-
guing that there exists, within the contemporary ﬁeld of global to-
bacco control, what I term temporalities and spaces of modernisation
that have been extremely inﬂuential and stand in stark contrast to the
spatial and temporal logics of globalisation. To do so, I examine a
statistical model of the global smoking epidemic that has shaped the
way tobacco control advocates have thought for the last twenty years
and which was elaborated by epidemiologist Alan Lopez and his col-
leagues at the World Health Organisation (WHO) in the early 1990s.
Speciﬁcally, drawing on extensive archival and ethnographic research
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on the international tobacco control movement,1 I unpack how this
model links the different temporal phases of the epidemic with par-
ticular disease patterns, public health policies, geographical regions
and levels of development. I also show how many of its assumptions
can be traced back to postwar modernisation and development the-
ories. I conclude by exploring what this might mean for our under-
standing of global health. But, before doing so, I examine the tem-
poralities and spaces of globalisation that can be found in much of the
literature on global health.
2. Temporalities and spatialities of globalisation
In The Condition of Postmodernity, geographer David Harvey
argued that the world was experiencing a ‘time–space
compression’:
As space appears to shrink to a ‘global village’ of tele-
communications … and as time horizons shorten to the point
where the present is all there is … so we have to learn to cope
with an overwhelming sense of compression of our spatial and
temporal worlds (Harvey, 1989, p. 240).
He further observed that this time–space compression, which
had been on-going since at least the mid-nineteenth century, had
recently accelerated because of radical changes in the nature of
capitalism and revolutions in transport and communication tech-
nologies. While particularly inﬂuential, Harvey was certainly not
alone in articulating these ideas. Indeed, the last decades of the
twentieth century saw a growing number of publications and
debates on this topic, so much so that ideas about time–space
compression and globalisation more generally had gained wide-
spread acceptance by the late 1990s (May and Thrift, 2001;
Scholte, 2005).
It is therefore no surprise that these ideas have been so inﬂu-
ential among many of those writing on global health over the last
ﬁfteen years (e.g. Walt, 2000; Lee and Collin, 2005).2 Borrowing
from the work of Marshall McLuhan, David Harvey, Anthony
Giddens and others, these writers imagine that the post-Cold War
period has been marked by ‘a process of increasing economic,
political and social interdependence and global integration’ (Yach
and Bettcher, 1998, p. 735). ‘Time and space’, they feel, is ‘collap-
sing’ (Yach and Bettcher, 2000, p. 206). The world is becoming a
‘global village’ (Lee and Collin, 2005, p. 15) with ‘a sense of
transworld simultaneity and instantaneity’ (Lee, 2003, p. 105) and
a ‘shared cosmopolitan culture’ (Yach and Bettcher, 2000, p. 206).
Following the literature on globalisation, these writers view this
‘process of closer integration’ as being the result of two key factors
(Walt, 2000, p. 1). The ﬁrst is ‘neoliberalism’ and, speciﬁcally,
‘trade liberalisation’ (Lee, 2003, p. 65; Harman, 2012, p. 5). The
second is the ‘revolution in communications and transportation
technologies’ from the Internet to the aeroplane (Daulaire, 1999, p.
22). These factors, they believe, enable the ever growing ‘ﬂows of
information, goods, capital and people across political and geo-
graphical boundaries’ that bring about a global convergence of
social, political and economical life (Daulaire, 1999, p. 22).
What is innovative in these writings on global health is the way
they conceive public health and biomedicine through the lense of
globalisation and time–space compression (Brown et al., 2006;
Fassin, 2012). Thus, for these writers, the world is ‘a global health
village’ characterised by a convergence of disease patterns, bio-
medical expertise and public health interventions (Yach and
Bettcher, 2000, p. 736). Often, these arguments are made in rela-
tion to infectious diseases (e.g. Garrett, 1995; Weinberg, 2005;
Youde, 2012). Many of these writers argue, for example, that the
development of air travel has led to ‘the microbial uniﬁcation of
the world’ by allowing for the rapid spread of pathogenic micro-
organisms (Berlinguer, 1999, p. 18). Another illustration is the way
in which the development of new Internet-based, epidemiological
surveillance systems allow public health authorities across the
globe to know about and prepare against pandemics ‘in real-time’
as they unfold (e.g. Weir and Mykhalovskiy, 2010; Caduff, 2014).
Importantly for us, many commentators writing on global
health have applied ideas about globalisation and time–space
compression to their analysis of NCDs and their risk factors. Some
of them have written on the relationship between trade liberal-
isation in the food industry and the rise of unhealthy diets and
NCDs like diabetes (e.g. Smith, 2003; Chopra, 2005). Others have
explored the impact of globalisation on the alcohol industry and
the chronic disease burden (e.g. Gilmore, 2009; Collin et al., 2014).
But, most of these commentators have focused on smoking (e.g.
Yach and Bettcher, 1999; Lee, 2003; Collin, 2005). The reasons for
this are mainly historical: smoking was the ﬁrst NCD risk factor to
be addressed in global health with the adoption of the WHO Fra-
mework Convention on Tobacco Control (FCTC) in the early 2000s
and now serves as a model for tackling other key NCD risk factors
(Yach et al., 2003; WHO, 2003; Casswell and Thamarangsi, 2009).
For these commentators, smoking is conceived as a ‘global epi-
demic’ deﬁned by worldwide mortality and morbidity ﬁgures. One
author, for example, argues that ‘the global tobacco epidemic’ kills
an ‘estimated four million people’ per year around the world
(Collin, 2003). ‘Transnational tobacco companies’, they suggest, are
the main driver of this epidemic (Collin, 2005, p. 114). Taking ad-
vantage of recent trade liberalisation efforts, these companies are
expanding their markets around the globe through sophisticated
advertising and marketing campaigns purporting to spread a
‘shared [smoking] culture’ articulated around ‘global [cigarette]
brands’ and the notion of ‘the global smoker’ (Yach and Bettcher,
1999; Collin, 2003). These different commentators also draw on
ideas about globalisation and time–space compression to rethink
the public health strategies deployed to stop the smoking epi-
demic. To illustrate, some argue that in order to ‘impact tobacco
consumption throughout the world’ one needs ‘global norms and
legal instruments’ such as the FCTC (Yach and Bettcher, 1998, p.
740; Harman, 2012, p. 38). Similarly, others comment that new
communication technologies like the Internet have ‘profoundly
improved’ the ‘prospects for global advocacy’ by allowing experts
and activists everywhere to ‘interact simultaneously’ (Yach and
Bettcher, 1998; Yach and Bettcher, 2000).
1 This research was articulated around three, main data collection strategies:
(1) articles were gathered from a literature search on global tobacco control in
major online databases and the British Library catalogue; (2) documents were
obtained from organisations active in global tobacco control such as the WHO and
the Framework Convention Alliance; and (3) over 100 semi-structured interviews
were conducted with tobacco control experts and advocates in accordance with
standard ethical principles and procedures (cf. Latour, 1993; Prainsack and Wahl-
berg, 2013). This corpus of texts and interviews was examined to identify the no-
tions of temporality and spatiality around which the advocates and experts that
make up the global tobacco control movement conceptualise, narrate and experi-
ence the smoking epidemic. Although these advocates and experts often come from
different socio-economic and geographical backgrounds, it is important to note that
their styles of thinking and reasoning are remarkably similar and consistent over
time (Fleck, 1979; Hass, 1992; Hacking, 2002).
2 While the literature on globalisation and health has been very inﬂuential
within the ﬁeld of global health, it has existed alongside two other bodies of work.
The ﬁrst is the research on cost-effectiveness and the global burden of disease
carried out by epidemiologists and economists like Dean Jamison, Christopher
Murray and Alan Lopez. Concerned with health planning and ﬁnancing in low- and
middle-income countries, this work does not engage with theories of globalisation
and is, like the Lopez model, markedly inﬂuenced by modernisation theories (e.g.
Jamison et al., 1993; Murray and Lopez, 1996). The second is the anthropological
and geographical research that is deeply sceptical of the global and celebrates the
local, emphasising resistance to, mistranslation and re-appropriation of biomedical
and public health discourses by community leaders, doctors and patients in par-
ticular places (e.g. Kelly and Beisel, 2011; Livingstone, 2012; Lawhon and Herrick,
2013).
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3. Contextualising the Lopez model
There is no doubt that these temporalities and spatialities of
globalisation play an important role within today's global health
ﬁeld, but they are certainly not the only concepts of time and
space to shape this ﬁeld. The temporal and spatial forms asso-
ciated with an inﬂuential epidemiological model of the smoking
epidemic elaborated by Alan Lopez and others are a good example
of such alternative concepts of time and space.3 But, before we
look at these forms in more detail, it is important we discuss the
context in which the model was developed. Lopez's model – which
outlines how the smoking epidemic develops in a population over
time by charting changes in prevalence, mortality, public attitudes
and policies – was designed in the early 1990s by three WHO
experts: Lopez, an Australian demographer who worked as chief
epidemiologist for the Geneva-based organisation's Tobacco or
Health Programme (THP); Neil Collishaw, a sociologist and long-
term anti-smoking advocate from Canada also based at the THP;
and Tapani Piha, a specialist in community medicine from Finland
who worked on tobacco control for the WHO's Regional Ofﬁce for
Europe (WHO Europe). The three men outlined their epidemiolo-
gical model in an article entitled ‘A Descriptive Model of the Ci-
garette Epidemic in Developed Countries’, which appeared in 1994
in Tobacco Control – the leading journal in the ﬁeld of international
tobacco control (Lopez et al., 1994).
The Lopez model was part of growing international efforts to
address the smoking epidemic at the time (Reubi and Berridge,
forthcoming). The internationalisation of tobacco control has a
long history stretching back to the 1960s and the organisation of
the World Conferences on Tobacco or Health every few years. But,
it is really from the 1980s onwards that international efforts in the
ﬁeld really picked up. One important initiative, though probably
not as inﬂuential as the International Union against Cancer's
Smoking and Cancer Programme, was the THP where Lopez and
Collishaw devised their model. As the WHO's ﬁrst permanent
programme on tobacco control, the THP was an understaffed and
underfunded operation that, among others, developed standardi-
sation protocols for smoking prevalence surveys and carried out
capacity building workshops in the developing world (Chollat-
Traquet, 1990). Another similar initiative, albeit a more regional
one, was the Action Plan for a Tobacco-Free Europe launched by
WHO Europe and for which Piha was a consultant (WHO Europe,
1993). An important aspect of international tobacco control efforts
during this period was the problematisation of smoking in what
was then called ‘the Third World’ (Reubi, 2013). Up to the 1980s,
experts thought that chronic diseases and contributing risk factors
like smoking were exclusive to the rich, industrialised nations of
the North and that the developing world was all about infectious
diseases, malnutrition and poverty. The publication of the WHO
report on Smoking Control in Developing Countries in 1983 marked
a shift in thinking (WHO, 1983). Increasingly, there was a re-
cognition that the smoking epidemic was spreading to the Third
World. This, it was imagined, was the result of raising disposable
incomes associated with successful economic development and
modernisation as well as the tobacco industry's efforts to create
new markets throughout Latin America, Asia and Africa. It was to
prevent developing countries facing the additional burden of
smoking-related diseases that international initiatives like the THP
sought to build tobacco control capacity in the Third World.
The Lopez model was also part of late-twentieth century efforts
by epidemiologists to formulate credible, global estimates for
smoking prevalence and smoking-attributable mortality. At the
time, there were a lot of doubts about the reliability of the num-
bers on smoking produced by the WHO. As an expert involved in
international tobacco control efforts during this period
remembered:
We always questioned smoking statistics in those days. Espe-
cially those from the WHO, which we thought must simply be
wrong.
These doubts were not limited to the data about smoking
prevalence and smoking-attributable mortality but extended to
the global mortality estimates for most diseases and risk factors
published by the WHO (Smith, 2013). The reasons for these doubts
were multiple. First, in many countries – indeed, most developing
countries – there were no nation-wide surveys on smoking habits
and no national death registers from which to draw data on to-
bacco-related mortality (Mackay and Crofton, 1996). Second, the
epidemiological models to estimate smoking prevalence and
smoking-attributable mortality when data was missing were often
very crude (WHO, 1990). Third, there were many instances of
double-counting within WHO, with all departments attributing
deaths to the diseases for which they were responsible to increase
their funding (Smith, 2013). The increasing numbers of epide-
miological investigations that were conducted around that time
were often framed as a solution to these problems of reliability.
Alan Lopez himself was closely associated with two of these in-
vestigations, which directly fed into and shaped the model of the
smoking epidemic he developed with Collishaw and Piha. The ﬁrst
one was a research project led by Oxford epidemiologist Richard
Peto that computed more reliable, global ﬁgures for smoking-at-
tributable mortality using a novel estimation technique (Peto and
Lopez, 1990; Peto et al., 1994). The second investigation was the
Global Burden of Disease project led by Christopher Murray at
Harvard that sought to establish global estimates of mortality and
disability to allow for more rational policymaking (Murray and
Lopez, 1996).
The Lopez model has been and continues to be hugely inﬂu-
ential in the ﬁeld of global tobacco control. The article in Tobacco
Controlwhere the model was outlined in 1994 has been cited more
than 850 times according to Google Scholar. Unsurprisingly, most
experts and activists in the ﬁeld know and regularly refer to it. As
two high-proﬁle tobacco control experts observed:
The Lopez model has been incredibly inﬂuential … It is still
used as a frame of reference today even though it was pub-
lished 20 years ago.
[The Lopez model] is still as valid today as it was twenty years
ago. I still very much use it my work. For all its potential pro-
blems, it generally ﬁts what is going on.
The importance of the model in shaping the thinking of tobacco
control advocates around the globe was also recently recognised
by the editors of the leading journal in the ﬁeld: Tobacco Control.
The journal's 20-year anniversary issue, which sought to review
‘the major achievements’ in the ﬁeld, contained one article by
Peto, Lopez and others in which they revisited and, aside from a
change to smoking and smoking-attributable mortality rates for
women, conﬁrmed the overall validity of their 1994 ‘landmark
model’ in the light of new epidemiological data (Malone and
Warner, 2012, pp. 72–73; Thun et al., 2012). The model has also
been very inﬂuential for advocacy and policymaking. Indeed, both
tobacco control experts and historians agree that, together with
the new epidemiological estimates provided by Peto and his
3 As science and technology studies have suggested (e.g. Evans, 1999; Morgan
and Morrison, 1999; Sismondo, 1999), scientiﬁc models like the epidemiological
model devised by Lopez and his colleagues are best understood as heterogeneous
assemblages of scientiﬁc theory, mathematical techniques, moral values, social
categories, graphic representations, empirical data and narratives. At once re-
presentations, predictions and tools for intervention, they are critical in the pro-
duction of contemporary scientiﬁc and political truths.
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colleagues, it played a decisive role in the adoption of the FCTC in
the early 2000s (Reynolds and Tansey, 2012). More recently, ex-
perts mandated by the Bill and Melinda Gates Foundation used the
Lopez model to show the surprisingly large number of lives that
could be saved through the prevention of the upcoming smoking
epidemic in sub-Saharan Africa, legitimising thereby the philan-
thropy's efforts to develop a tobacco control movement across the
subcontinent (Blecher and Ross, 2014).
4. Of time and space in the Lopez model
To unpack the notions of time and space that underpin the
Lopez model, one needs to examine the way the model imagines
the smoking epidemic. As already mentioned, the model outlines
how the epidemic develops in the population of a country over a
hundred-year time period. The model is based on statistical data
from a few Western countries and, in particular, the USA and the
UK, which were among the ﬁrst to experience the epidemic and
where there has been the necessary epidemiological infrastructure
to record smoking prevalence and smoking-related mortality
(Berridge, 2007; Brandt, 2007). Many of the assumptions around
which the Lopez model is built, such as the hundred-year period
over which the epidemic is represented, derive from the particu-
larities of this data. The model identiﬁes four successive, 25-year
long phases – which Lopez and his colleagues term Stage I, Stage II,
Stage III and Stage IV – through which the epidemic unfolds. For all
four stages, the epidemic is characterised along three explicit
variables. The ﬁrst is smoking prevalence, understood as ‘the
percentage of the adult population who smoke regularly’ (Lopez
et al., 1994, p. 243). The second is smoking-related mortality, de-
ﬁned as the ‘numbers of deaths’ caused by smoking ‘through a
variety of diseases, principally several sites of cancer, major vas-
cular diseases and chronic lung diseases’ (Lopez et al., 1994, p.
243). Given the difference in smoking patterns among men and
women in the USA and UK, the model further breaks down these
ﬁrst two variables by male and female. The third variable, which
unlike the ﬁrst ones is not numerical, is public attitudes to
smoking and the state of tobacco control policies.
Lopez and his colleagues offer both a narrative and a graphic
account of the four stages of the epidemic using these three
variables (cf. Fig. 1). Stage I describes the beginning of the smoking
epidemic: male prevalence starts rising reaching 15%, while female
prevalence remains low ‘because of socio-cultural factors’ which
discourage women from smoking; ‘death and disease due to
smoking are not yet evident’; and ‘smoking becomes socially ac-
ceptable and tobacco control strategies remain underdeveloped,
with priority being given to reducing malnutrition and the burden
of infectious diseases’ (Lopez et al., 1994, p. 244). Stage II sees the
epidemic develop further: male prevalence continues to grow ra-
pidly, peaking at 60%; female prevalence increases dramatically to
reach over 30%; smoking-related deaths among men start rising,
typically mirroring the rise in smoking prevalence with a twenty-
year time-lag because of the late onset of lung cancer, chronic
obstructive pulmonary disease and some cardio-vascular diseases;
and tobacco control policies remain weak, with ‘a lack of public
and political support, in part because of the risks of tobacco use
may still not be widely understood’ (Lopez et al., 1994, p. 244).
Stage III seems to represents a turning point in the epidemic:
‘male prevalence begins to decline’ to around 40% while female
prevalence plateaus at 40% before decreasing; smoking-related
mortality among men rises dramatically, accounting for 30% of all
deaths by the close of the period; smoking-attributable mortality
among women also starts to grow; at the same time, public atti-
tudes to smoking change, with ‘knowledge about the health ha-
zards of tobacco [now] generally widespread’ and smoking be-
coming a ‘socially abnormal behaviour’ leading to the im-
plementation of tobacco control policies (Lopez et al., 1994, pp.
244–245). Stage IV represents the tail end of the epidemic:
‘smoking prevalence for both sexes continues to decline’; smok-
ing-related mortality among men begins to slowly decrease, while
mortality among women is still increasing, reaching 20% by the
end of the stage; and public attitudes towards smoking harden
and anti-smoking policies become more comprehensive (Lopez
et al., 1994, p. 245).
Crucially for the argument made here, there is a fourth, un-
spoken variable along which Lopez and his colleagues characterise
the smoking epidemic: the level of economic development of the
country in which the epidemic is unfolding. Indeed, they implicitly
posit that the more developed a country is, the more it will have
progressed through the stages of the smoking epidemic. Moreover,
they tacitly associate the level of development and stages of the
epidemic with different geographical regions. This is evident in the
way Lopez and his colleagues relate particular stages of the
Fig. 1. The model of the smoking epidemic as found in Lopez’ 1994 Tobacco Control article.
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epidemic to particular countries. Thus, they explain that ‘many
developing countries, primary in sub-Saharan Africa, are currently
in Stage I’, which is characterised by growing smoking prevalence
rates among men and no tobacco control policies because of the
prioritisation of malnutrition and infectious diseases by govern-
ments and health experts (Lopez et al., 1994, p. 246). Similarly,
they assert that countries that are further along in their economic
development ‘such as China, Japan and other countries of Asia,
Latin America and North Africa’ are in Stage II, which is typiﬁed by
dramatic increases in smoking prevalence, a lack of awareness
about the dangers of tobacco and weak tobacco control policies
(Lopez et al., 1994, p. 246). In contrast, they argue that most of the
rich, industrialised ‘countries of Western Europe, along with Aus-
tralia, Canada and the US, are nearing the end of Stage III or [have
passed] into Stage IV’, which are marked by a decline in smoking
prevalence, public opposition to smoking and comprehensive to-
bacco control policies (Lopez et al., 1994, pp. 245–246).
By linking smoking with development and geography, Lopez
and his colleagues were tapping into ideas about tobacco in the
developing world that had become common among public health
experts after the early 1980s, when smoking was being identiﬁed
as a problem for the Third World (Reubi, 2013). One such idea was
the notion that developed and developing countries were at op-
posite ends of the smoking epidemic (e.g. WHO, 1983; Peto et al.,
1994). In the former, it was thought, the epidemic was subsiding,
while in the latter, the epidemic was only just beginning. As a
prominent tobacco control expert argued:
The difference between developed and developing countries is
one of timing … A lot of what is going on right now in the
developing world is not dissimilar to what went on in the de-
veloped world, many, many decades ago.
Closely related to this ﬁrst idea was the view that ‘smoke-and-
health consciousness in [developing] societies lags behind that of
the developed world by two or three decades’ (Warner, 1984, p.
37). As one academic with an extensive experience of the global
tobacco control ﬁeld noted:
In many developing countries, you do not see any support for
tobacco control at any level – no governmental policies, no
governmental agencies, no anti-smoking movement, no re-
search. There is just not much of anything.
Another important idea about smoking and development that
dominated the global tobacco control ﬁeld after the 1980s was the
notion that the two major causes of the tobacco epidemic in the
Third World were: (1) the successful economic development of
countries in the global South, which meant that their citizens were
getting richer and had more spending power for discretionary
items like cigarettes; and (2) the tobacco industry's expansion into
the developing world to take advantage of this new spending
power and compensate their declining sales of cigarettes in the
North (e.g. WHO, 1983; Stebbins, 1990; Warner, 2000). Un-
surprisingly perhaps, many international tobacco control ad-
vocates bemoaned the relationship between successful economic
development and increasing smoking rates, describing it as ‘de-
fective modernisation’ and an illustration of ‘the Third World
modernising all too quickly’ (Warner, 1984, p. 37; Stebbins, 1990, p.
228).
The Lopez model did not just reiterate these pre-existing ideas
about smoking and development, it elaborated them further. To
start with, the model made it clear that not all developing coun-
tries were the same in terms of smoking patterns, public attitudes
to smoking and tobacco control policies. As mentioned above, it
tacitly assumed that countries that were more developed were at a
more advanced stage of the tobacco epidemic. And it correlated
these differences in smoking and development to particular geo-
graphical regions, with Asian and Latin American nations asso-
ciated with higher levels of development, greater smoking pre-
valence and superior tobacco control programmes than African
societies. As one international activist observed:
The model shows that you cannot lump all developing coun-
tries together … there are Asian and Latin American countries
that one might still refer to as developing countries where
there is heavy smoking by males, very low smoking by females
… there are African countries where smoking is still relatively
novel, where smoking is still very much on the rise and very
much at the beginning of the epidemic.
Furthermore, the Lopez model also bestowed many of these
pre-existing ideas about development and smoking with scientiﬁc
legitimacy. It did so by translating these ideas into numbers and
graphs and by having them published in an internationally re-
cognised academic journal (Latour, 1990; Porter, 1995). This was
important for global tobacco control activists, who had come to
view scientiﬁc truth as a marker of their moral integrity and an
advantage they had over the tobacco industry (Larsen, 2008).
It is important to note that the Lopez model's relationship with
developed countries is not the same as with developing ones. For
the former, the model is ‘historical in nature’ in the sense that they
are currently in Stage IV after having effectively gone through the
previous three stages (Lopez et al., 1994, p. 245). In contrast, for
the latter, the model is more dynamic. Indeed, while these coun-
tries are currently located in Stage I or Stage II, their future is still
indeterminate to a certain extent. One prospect is to do like de-
veloped societies have done before and go through the next 2 or
3 stages of the epidemic as described in the Lopez model. That
means letting the epidemic follow its course before tackling it in
Stage III and Stage IV. But, as Lopez and his colleagues point out,
developing countries ‘can prevent history repeating itself’ and
chose for themselves a better, healthier future (Lopez et al., 1994,
p. 245). This necessitates them taking ‘strong public health mea-
sures to arrest the growth of tobacco consumption’ at ‘earlier
stages of the epidemic’ and, speciﬁcally, ‘during Stage I or Stage II’
(Lopez et al., 1994, pp. 245–246). This, of course, was possible
because of the extensive knowledge about smoking and how to
tackle it accumulated by experts in the global North. As Lopez and
his colleagues explained, developing countries ‘have the advantage
of knowing the serious health consequences of smoking’ and have
at their disposal an array of already existing, ‘effective prevention
interventions’ to address the problem (Lopez et al., 1994, p. 245).
Intriguingly, Lopez and his colleagues use the case of Singapore
– the poster child of successful economic development and mod-
ernisation – to illustrate their point (Reubi, 2010). As they explain,
in the 1970s, the Southeast Asian Republic was both at the start of
its development effort and ‘in the early part of Stage II of the ci-
garette epidemic’, with smoking prevalence of about 42% among
men and 10% among women and weak tobacco control policies
(Lopez et al., 1994, p. 246). Twenty years later, in the 1990s, at a
time when Singapore was close to becoming a developed nation, it
should have, if it had let the epidemic run its course unchecked,
been entering Stage III, with smoking prevalence at 60% among
men and 40% among women and still weak anti-smoking policies.
Instead, it had, in the 1970s, adopted comprehensive tobacco
control measures borrowed from Europe and North America,
which had brought smoking prevalence rates down to 33% among
men and 3% among women – ﬁgures that were more akin to the
end of Stage IV than the start of Stage III. In other words, at the
same time that the Asian city–state was going through an ac-
celerated process of modernisation, it had also achieved to pro-
gress through Stages II and III of the smoking epidemic at about
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two to three times the ‘normal’ speed.
5. Temporalities and spaces of modernisation
Many of the spatio-temporal notions that underpin the work of
Lopez and his colleagues can be traced back to the modernisation
and development theories that dominated the ﬁeld of interna-
tional politics after World War II (Escobar, 1995; Ekbladh, 2011). As
Wahlberg (2007) shows, these theories are built around a dis-
tinctive conception of human progress centred on nation–states
and stages of development. For proponents of these theories, all
states and their populations go through the same sequence of
stages as they progress from underdevelopment to development.
Modelled on the history of the rich, industrialised nations of North
America and Europe, these stages are characterised by particular
social, political, economic, demographic and epidemiological
conditions. As Wahlberg (2007) further shows, there were many
examples of this way of conceptualising and grading progress in
the development literature. An inﬂuential one was the model
outlined by Walt Rostow in The Stages of Economic Growth. At one
end of the development continuum was ‘traditional society’,
which, Rostow thought, was characterised by ‘pre-Newtonian
science and technology’, ‘family and clan connexions’, ‘fatalism’
and a reliance on ‘agriculture’ (Rostow, 1960, pp. 4–5). At the other
end was ‘the age of high mass-consumption’ typiﬁed by high ‘in-
come’, an ‘urban’ population ‘working in ofﬁces’ and ‘durable
consumer goods’ such as ‘automobiles’ (Rostow, 1960, pp. 10–11).
In-between these two poles, Rostow (1960, pp. 6–10) talked about
‘take-off’ and ‘drive to maturity’, which he associated with the
‘building of an effective centralised national state’, the emergence
of ‘banks and institutions for mobilising capital’, a ‘new type of
enterprising men’, ‘new industries’ and an embrace of ‘modern
science’.
Another inﬂuential example of this way of conceptualising
progress was Abdel Omran's paper on The Epidemiological Transi-
tion. The distinctive aspect of Omran's work was the addition of
demographic and epidemiological dimensions to the stages of
development sketched by Rostow. So, according to Omran (1971,
pp. 533–534), traditional society, which he termed ‘the Age of
Pestilence and Famine’, was not just deﬁned by the social, political
and economic traits outlined by Rostow but also by high fertility,
low life expectancy, infectious diseases and malnutrition. Likewise,
Omran (1971, pp. 533–534) posited that Rostow's age of mass-
consumption, which he called ‘the Age of Degenerative and Man-
Made Disease’, was not only characterized by a central state, in-
dustrialisation and science but also low fertility, high life ex-
pectancy, ageing populations and chronic disease. Most of these
ideas developed by Rostow and Omran could be found in what was
probably the most inﬂuential postwar conceptualisation of human
progress: the categories of ‘Industrialised Countries’ (First World),
‘Centrally Planned Economies’ (Second World) and ‘Middle and
Low Income Countries’ (Third World) outlined by the World Bank
in its ﬁrst World Development Report (World Bank, 1978, p. ix).
Indeed, the Bank associated development not only with ‘economic
growth’, industrialisation, ‘improvements in transportation, com-
munications and electric power’, a ‘dynamic entrepreneurial class’
and ‘technological sophistication’, but also with ‘a rapid expansion
of education systems, growing literacy, improvements in nutrition
and health conditions’, ‘greater urbanisation’ and ‘reduced fertility’
(World Bank, 1978, pp. 1–7).
These stages of development allowed experts in the ﬁeld to
judge the progress and development of nations by situating them
in both time and space. Unsurprising, North American and Eur-
opean countries were deemed to be in the later stages of devel-
opment and associated with progress and modernity. To illustrate,
Rostow (1960, p.11) linked his age of high mass-consumption with
‘the United States’, ‘Western Europe and Japan’. In contrast, the
poor, developing nations of the global South were thought to be in
the earlier stages of development and viewed as traditional and
backwards. In its 1978 report, for example, the Bank identiﬁed
most countries in sub-Saharan Africa as Low Income while it de-
scribed the majority of nations in Southeast Asia and Latin
America as Middle Income (World Bank, 1978). The location of a
country in time and space, however, was not immutable. Speciﬁ-
cally, modernisation theorists thought that Third World countries
could improve their levels of development and move to a more
advanced stage, thus reducing the spatio-temporal gap that se-
parated them from North America and Europe (Ekbladh, 2011).
Such efforts at accelerated development were made possible by
technical and ﬁnancial assistance from developed countries and
generally involved the establishment of a strong, centralised state
together with the creation of the physical infrastructure and hu-
man resources necessary for rapid industrialisation (Reubi, 2010).
The parallels between modernisation theories and the Lopez
model are readily apparent. To start with, both are articulated
around the idea that all countries go through the same successive
stages – stages of development for modernisation theories; stages
of the smoking epidemic for the Lopez model. Furthermore, in
both cases, these stages are modelled on the history of Europe and
America, assuming thereby that all developing countries should
follow the same path as the rich, industrialised nations of the
global North. This assumption has, in the case of modernisation
theories, been extensively criticised for foreclosing alternative
paths of development (Escobar, 1995). It has also been problematic
for the Lopez model, with, for example, women in most devel-
oping countries not taking up smoking as the model predicted
(Thun et al., 2012). Another parallel between modernisation the-
ories and the Lopez model is that they both characterise each of
the stages a country goes through by an amalgam of economic,
political, social, demographic and epidemiological features. Simi-
larly, in both cases, the sequence of stages is used to position a
country in time and space, making it possible to group it with
some nations and differentiate it from others. Finally, both mod-
ernisation theories and the Lopez model assume that a country in
the early stages of development or the smoking epidemic can, by
drawing on the knowledge accumulated by experts in North
America and Europe, choose to progress faster through the re-
maining, successive stages.
6. Conclusion
I have sought to draw attention to some of the temporal and
spatial logics at work in the ﬁeld of global health and chronic
disease. As I showed, many commentators writing on global health
have been strongly inﬂuenced by globalisation theories and no-
tions of time–space compression. The world, they believe, is be-
coming a ‘global village’ characterised by temporal simultaneity
and a convergence of political, economical and social life. This
process of convergence, they also believe, is the result of the ever-
growing global ﬂows of information, goods, capital and goods
across political and geographical boundaries made possible by
trade liberalisation and revolutions in communication and trans-
portation. Applying these ideas to health, they argue that the
world is increasingly characterised by a global convergence of
disease patterns, biomedical knowledge and public health strate-
gies. To validate their claims, these commentators point out to a
range of recent developments in global health. Some relate to in-
fectious diseases such as the rapid spread of microbes associated
with air travel and Internet-based, epidemiological surveillance
systems that allow public health authorities to tackle epidemics ‘in
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real-time’. But many others relate to chronic diseases and the
smoking epidemic in particular, including: the worldwide dis-
semination of unhealthy behaviours like smoking brought about
by trade liberalisation and multinational tobacco corporations;
transnational anti-smoking advocacy networks made possible by
Internet-based, communication technologies; and the adoption of
global public health norms like those of the FCTC.
There is little doubt that temporalities and spatialities of glo-
balisation shape many of the institutions, theories and practices
that make up the contemporary ﬁeld of global health and chronic
disease. But, as I argued in the article, they are not the only notions
of time and space at work within this ﬁeld. Rather, they work
alongside many other, often-contradictory spatio-temporal logics.
The temporalities and spatialities underpinning the Lopez model
explored in this article are a case in point. Unlike the temporalities
and spatialities of sameness described in much of the literature on
global health, the Lopez model is articulated around temporalities
and spatialities of difference. This, of course, is not the difference
celebrated by postmodern thinkers (e.g. Lyotard, 2004; Bauman,
2005), but the difference of modernisation theories built around
nation–states, sequential stages and progress. Indeed, the Lopez
model, in stark contrast to the ‘one world, one time, one health’
mantra of globalisation, divides the world into nation–states and
orders them along epidemiological, geographical and develop-
ment lines.
More generally perhaps, this article also speaks and contributes
to the growing body of critical studies in global health (e.g. Fassin,
2012; Biehl and Petryna, 2013; Anderson, 2014). According to
these scholars, the ﬁeld of global health is characterised by ‘ten-
sions and contradictions’ as well as ‘failures and resistances’
(Fassin, 2012, p. 107 and 113). They encourage us to recognise this
‘uneven terrain’ and think of ‘the globalisation of health … as a
heterogeneous and contested historical phenomenon’ (Fassin,
2012, p. 99; Anderson, 2014, p. 372). This article very much follows
this lead, depicting how different, even contradictory spatio-
temporal logics, each with their own strengths and weaknesses,
work alongside each other within the global health ﬁeld. Fur-
thermore, it shows the importance of knowledge and expert dis-
courses such as globalisation and modernisation theories in the
making of the notions and practices that are part of and inform
contemporary global health, something also repeatedly empha-
sised in critical studies of global health (e.g. Lakoff and Collier,
2008; Reubi, 2013; Gaudillière, 2014).
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